Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| CUREVAC | 4 | 9 | +1,16 % | ||
| VANDA PHARMACEUTICALS | 4 | - | -1,31 % | ||
| REGENERON PHARMACEUTICALS | 3 | 22 | +0,89 % | ||
| BIONTECH | 3 | 13 | +1,36 % | ||
| HUTCHMED | 3 | 7 | -1,71 % | ||
| ANAVEX LIFE SCIENCES | 3 | - | +1,16 % | ||
| NEUROCRINE BIOSCIENCES | 2 | 17 | -0,69 % | ||
| VERA THERAPEUTICS | 2 | 9 | +1,14 % | ||
| STRUCTURE THERAPEUTICS | 2 | 1 | +2,19 % | ||
| BIOGEN | 1 | 54 | +0,35 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:54 | If You Invested $1000 In argenx Stock 5 Years Ago, You Would Have This Much Today | 2 | Benzinga.com | ||
| 17:42 | Absci stock price target raised to $9 from $8 at Jones Trading | 1 | Investing.com | ||
| 17:30 | FDA re-review of Vanda tradipitant partial clinical hold extended | 2 | Seeking Alpha | ||
| 17:27 | BioNTech: CureVac-Übernahme kurz vor Abschluss | 235 | börsennews.de | Die BioNTech-Aktie wird aktuell bei 88 EUR gehandelt und gewinnt wieder an Dynamik. Während die Übernahme von CureVac in ihre finale Phase eintritt, sorgen gleichzeitig neue Forschungs-Updates und Analystenkommentare... ► Artikel lesen | |
| 17:26 | Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations | 1 | Insider Monkey | ||
| 17:18 | FDA Fast-Tracks Vanda's Motion Sickness Drug Review After Leadership Shake-Up | 1 | Benzinga.com | ||
| 16:30 | Curevac-Aktie zündet völlig unerwartet die nächste Stufe - Analysten sind alarmiert und rätseln über die wahren Gründe - die nächsten Tage könnten brutal werden - in beide Richtungen. | Hebelschein-Spekulant | |||
| 16:18 | Ascendis Pharma Hit By FDA Delay As TransCon CNP Decision Slips To 2026 | 1 | Benzinga.com | ||
| 16:10 | ANIP vs. AMRX: Which Niche Drugmaker Is the Better Pick? | 1 | Zacks | ||
| 14:10 | Bristol Myers vs Gilead Sciences: Which Biotech Stock Is a Better Bet Now? | 16 | Zacks | ||
| 14:06 | Neurocrine Bio. stock jumps as rival drug faces modest Medicare price cut | 3 | Investing.com | ||
| 13:58 | Neurocrine-Aktie im Aufwind: Geringer Preisabschlag für Konkurrenzmedikament von Teva | 26 | Investing.com Deutsch | ||
| 13:54 | Regeneron's Libtayo receives EC approval for skin cancer | 2 | PMLiVE | ||
| 13:54 | JPMorgan discloses securities dealings in Avadel Pharmaceuticals | 5 | Investing.com | ||
| 13:42 | Halozyme stock rating reiterated at Buy by H.C. Wainwright after Elektrofi acquisition | 10 | Investing.com | ||
| 13:42 | Anavex stock holds Buy rating at H.C. Wainwright amid Alzheimer's unmet need | 4 | Investing.com | ||
| 13:42 | Mizuho raises Arcutis Biotherapeutics stock price target on strong Zoryve sales | 1 | Investing.com | ||
| 13:42 | Mizuho maintains Outperform rating on Terns Pharmaceuticals stock ahead of ASH data | 3 | Investing.com | ||
| 13:42 | Vera Therapeutics stock steady as H.C. Wainwright reiterates Buy rating | 1 | Investing.com | ||
| 13:42 | Structure Therapeutics stock holds Buy rating at H.C. Wainwright ahead of key trials | 1 | Investing.com |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .